Sector Pharmaceuticals & Biotech. - Latest news, views and updates

Pharmaceuticals & Biotech.

SECTOR | 08 Jan 2025

Q3FY25 Earnings Preview - PHARMA & HEALTHCARE

Pharmaceuticals & Biotech.

Axis Direct

Q3FY25 Earnings Preview - PHARMA & HEALTHCARE

Pharmaceuticals & Biotech.

SECTOR | 02 Jan 2025

ICMR proposes revised version of National Essential Diagnostics List

Business Standard

The ICMR has proposed a revised version of the National Essential Diagnostics List (NEDL), which enumerates the minimum number of tests that should be available at various levels of healthcare facilities in the country. According to the revised draft, nine types of diagnostic tests, including those for diabetes, Malaria, TB, HIV and syphilis should be made available at the health centres in village-level health facilities. Ayushman Arogya Mandirs should have facilities for Hepatitis B tests available in addition to the nine diagnostics that are available at the village-level health centres. The revised draft list has been prepared incorporating inputs from relevant stakeholders and feedback from multiple consultation meetings. It builds upon the first list and provides recommendations for diagnostic tests across various levels of healthcare facilities, including village-level facilities, Ayushman Arogya Mandirs, primary health centre (PHCs), community health centres (CHCs), sub...

Pharmaceuticals & Biotech.

SECTOR | 01 Jan 2025

Pharma sector grappling with new realities at home and overseas

Business Line

Focus will be on ensuring sustained supplies to meet local and global needs

Pharmaceuticals & Biotech.

SECTOR | 31 Dec 2024

2024 science review: The 10 most intriguing breakthroughs of the year

Economic Times

Despite global turmoil, 2024 saw groundbreaking scientific advancements, including discovering the moon's far side, a new HIV prevention drug, AI's potential in mental health, and space missions to find extraterrestrial life. Quantum computing also progressed, while microplastics raised health concerns, further supported by studies on aging and climate fluctuation.

Pharmaceuticals & Biotech.

SECTOR | 24 Dec 2024

Medical devices maker Poly Medicure to focus on exports amid geopolitical shift

livemint

Apart from geopolitical shifts as countries look to move supply chains away from China, India's medtech industry can leverage the country's cost advantage - a lower cost of manufacturing, software and hardware talent as well as a growing electronics ecosystem - to boost exports, Himanshu Baid said.

Pharmaceuticals & Biotech.

SECTOR | 22 Dec 2024, 04:35PM

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

Business Standard

The ceiling prices of seven other drugs were revised to include the impact of the 0.00551 per cent increase in drug prices in the National List of Essential Medicines

Pharmaceuticals & Biotech.

SECTOR | 20 Dec 2024

Over 14,000 Janaushadhi Kendras Set Up To Make Generic Medicines Affordable, Says Nadda

NDTV Profit

This scheme provides health cover of Rs. 5 lakh per family per year for secondary and tertiary care hospitalisation to approximately 55 crore beneficiaries corresponding to 12.37 crore families constituting the bottom 40% of India's population.

Pharmaceuticals & Biotech.

SECTOR | 16 Dec 2024

Govt will curb manufacturing, sale of counterfeit medicines in UP: CM Yogi

Business Standard

The Uttar Pradesh government is committed to putting a stop on the manufacturing and sale of counterfeit medicines in the state, Chief Minister Yogi Adityanath said on Monday. Responding to a starred question raised by Samajwadi Party MLA Sachin Yadav during the Question Hour, the chief minister, in a written reply, said the government is taking stringent measures to curb this illicit trade. Yadav had asked whether the government intends to curb the manufacturing and sale of counterfeit medicines in the state and if details of actions taken against those involved would be presented before the House. The chief minister said the Food Safety and Drug Administration department has conducted a total of 24,492 enforcement actions, including 22,151 inspections and 2,341 raids. A total of 26,225 samples were collected, out of which 301 cases of counterfeit medicines were identified. Medicines valued at an estimated Rs 19.76 crore were seized, and legal cases were filed for 250 instances of

Pharmaceuticals & Biotech.

SECTOR | 11 Dec 2024

Maharashtra's Chhatrapati Sambhajinagar Medical College Halts Use Of Wholesaler-Supplied Medicines

NDTV Profit

The decision was taken after the company was named in a First Information Report for allegedly supplying spurious medicines to the Swami Ramanand Teerth Rural Government Medical College and Hospital in Ambajogai in Beed district last week, an official said.

Pharmaceuticals & Biotech.

SECTOR | 03 Dec 2024

Twice-yearly shot could help end AIDS; will it reach those who need it?

Business Standard

It's been called the closest the world has ever come to a vaccine against the AIDS virus. The twice-yearly shot was 100% effective in preventing HIV infections in a study of women, and results published Wednesday show it worked nearly as well in men. Drugmaker Gilead said it will allow cheap, generic versions to be sold in 120 poor countries with high HIV rates mostly in Africa, Southeast Asia and the Caribbean. But it has excluded nearly all of Latin America, where rates are far lower but increasing, sparking concern the world is missing a critical opportunity to stop the disease. This is so far superior to any other prevention method we have, that it's unprecedented, said Winnie Byanyima, executive director of UNAIDS. She credited Gilead for developing the drug, but said the world's ability to stop AIDS hinges on its use in at-risk countries. In a report issued to mark World AIDS Day on Sunday, UNAIDS said that the number of AIDS death last year an estimated 630,000 was at its